HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
P Hugh R Barrett Selected Research
P Hugh R Barrett Research Topics
Disease
27
Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2021 - 01/2003
23
Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 03/2002
21
Insulin Resistance
10/2015 - 06/2002
18
Dyslipidemias (Dyslipidemia)
11/2021 - 08/2002
15
Abdominal Obesity
10/2015 - 05/2002
14
Obesity
08/2016 - 05/2002
12
Atherosclerosis
01/2018 - 01/2002
9
Weight Loss (Weight Reduction)
11/2021 - 02/2003
9
Hypertriglyceridemia
10/2016 - 06/2003
8
Hyperlipidemias (Hyperlipidemia)
01/2017 - 09/2002
7
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
11/2021 - 03/2002
7
Hypobetalipoproteinemias (Hypobetalipoproteinemia)
06/2016 - 10/2004
6
Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 09/2002
5
Body Weight (Weight, Body)
08/2014 - 10/2009
5
Overweight
05/2010 - 01/2003
4
Type 2 Diabetes Mellitus (MODY)
12/2016 - 01/2002
4
Hypercholesterolemia
10/2013 - 03/2002
3
Coronary Disease (Coronary Heart Disease)
08/2014 - 02/2003
3
Malaria
12/2007 - 07/2002
2
Inflammation (Inflammations)
05/2016 - 05/2010
2
Hepatocellular Carcinoma (Hepatoma)
02/2003 - 09/2002
1
Carotid Stenosis (Carotid Artery Stenosis)
01/2018
1
Fatty Liver
08/2017
1
Hypertension (High Blood Pressure)
05/2016
1
Carotid Artery Diseases
05/2016
Drug/Important Bio-Agent (IBA)
37
Lipoproteins (Lipoprotein)
IBA
11/2021 - 01/2002
34
Apolipoproteins B (ApoB)
IBA
12/2016 - 01/2002
29
Triglycerides (Triacylglycerol)
IBA
12/2016 - 01/2002
28
Apolipoproteins
IBA
11/2021 - 01/2002
26
Apolipoprotein B-100 (Apo B 100)
IBA
11/2021 - 03/2002
19
Apolipoprotein A-I (Apolipoprotein A1)
IBA
11/2021 - 03/2003
16
oxidized low density lipoprotein
IBA
01/2018 - 09/2002
15
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2021 - 08/2002
13
Lipids
IBA
11/2021 - 06/2002
12
HDL Lipoproteins
IBA
11/2021 - 09/2004
12
Apolipoprotein C-III
IBA
10/2015 - 08/2002
12
HDL Cholesterol
IBA
08/2014 - 06/2005
11
LDL Lipoproteins (beta Lipoproteins)
IBA
01/2019 - 03/2002
11
Cholesterol
IBA
01/2018 - 03/2002
11
Atorvastatin (Lipitor)
FDA Link
11/2012 - 05/2002
10
Isotopes
IBA
11/2021 - 05/2002
10
Fish Oils
IBA
11/2021 - 06/2002
10
LDL Cholesterol
IBA
01/2018 - 09/2002
9
VLDL Lipoproteins
IBA
11/2021 - 01/2003
8
Adiponectin
IBA
04/2013 - 09/2004
7
Apolipoproteins A
IBA
01/2019 - 07/2006
7
Rosuvastatin Calcium (Crestor)
FDA Link
01/2017 - 02/2008
7
Fatty Acids (Saturated Fatty Acids)
IBA
10/2016 - 02/2004
7
Apolipoprotein B-48
IBA
03/2015 - 02/2003
7
Insulin (Novolin)
FDA Link
05/2010 - 08/2002
6
Lipoprotein(a)
IBA
11/2021 - 12/2015
6
LDL Receptors (LDL Receptor)
IBA
01/2018 - 03/2002
6
Fenofibrate (CiL)
FDA Link
Generic
11/2012 - 03/2003
6
Apolipoprotein A-II (Apolipoprotein A2)
IBA
05/2010 - 07/2006
5
Fibric Acids (Fibrates)
IBA
11/2021 - 02/2004
5
Chylomicrons
IBA
12/2016 - 02/2003
5
Leucine (L-Leucine)
FDA Link
10/2015 - 09/2002
4
Proteins (Proteins, Gene)
FDA Link
01/2017 - 02/2004
4
Niacin (Nicotinic Acid)
FDA Link
Generic
12/2016 - 09/2008
4
Apolipoproteins E (ApoE)
IBA
11/2012 - 01/2002
4
Interleukin-6 (Interleukin 6)
IBA
05/2010 - 06/2002
4
Omega-3 Fatty Acids (Omega 3 Fatty Acids)
IBA
04/2010 - 02/2003
3
Apoprotein(a) (Apolipoprotein (a))
IBA
01/2019 - 01/2018
3
naringenin
IBA
10/2008 - 09/2002
3
Cholesterol Ester Transfer Proteins
IBA
08/2008 - 02/2006
3
Proteoglycans (Proteoglycan)
IBA
11/2004 - 01/2002
3
Chylomicron Remnants
IBA
02/2003 - 05/2002
2
Proprotein Convertase 9
IBA
05/2016 - 08/2006
2
Palmitic Acid (Hexadecanoic Acid)
IBA
06/2015 - 06/2013
2
Sphingolipids
IBA
06/2015 - 11/2014
2
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
10/2011 - 05/2008
2
C-Reactive Protein
IBA
05/2010 - 06/2002
2
Vitamin A (Retinol)
FDA Link
Generic
05/2010 - 11/2007
2
lathosterol
IBA
05/2010 - 11/2009
2
Antimalarials (Antimalarial Agents)
IBA
12/2007 - 07/2002
2
Phytosterols (Plant Sterols)
IBA
01/2007 - 02/2003
2
Phospholipid Transfer Proteins
IBA
09/2006 - 03/2006
2
Nonesterified Fatty Acids (NEFA)
IBA
08/2006 - 03/2004
2
Ligands
IBA
08/2006 - 10/2004
2
Leptin
IBA
03/2005 - 03/2005
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2005 - 03/2005
2
Enzymes
IBA
03/2005 - 02/2004
2
Resistin
IBA
03/2005 - 03/2005
2
Biglycan
IBA
11/2004 - 01/2002
2
Biological Products
IBA
09/2004 - 02/2004
2
Flavonoids
IBA
02/2003 - 09/2002
1
Protein Isoforms (Isoforms)
IBA
01/2018
1
8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acid
IBA
01/2018
1
Tamoxifen
FDA Link
Generic
08/2017
1
low density lipoprotein inhibitor
IBA
01/2017
1
Esters
IBA
10/2016
1
Apolipoproteins C (ApoC)
IBA
08/2016
1
very low density lipoprotein triglyceride
IBA
10/2015
1
Glycerol (Glycerine)
FDA Link
Generic
10/2015
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
06/2015
1
Ceramides
IBA
06/2015
1
Phospholipids (Phosphatides)
FDA Link
Generic
11/2014
Therapy/Procedure
8
Therapeutics
08/2017 - 07/2002
3
Fat-Restricted Diet (Diet, Fat Restricted)
05/2010 - 11/2007
3
Drug Therapy (Chemotherapy)
05/2010 - 02/2004